Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$17.76
-4.3%
$27.43
$13.74
▼
$40.99
$4.13B2.5322.21 million shs9.97 million shs
KLA Corporation stock logo
KLAC
KLA
$142.29
-1.2%
$172.16
$107.20
▼
$307.37
$185.40B1.4911.41 million shs8.67 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$40.53
-2.6%
$39.99
$35.12
▼
$64.16
$181.10B0.716.31 million shs13.03 million shs
QXO, Inc. stock logo
QXO
QXO
$11.22
-6.6%
$11.72
$10.03
▼
$27.61
$11.61B2.4216.58 million shs17.17 million shs
SK hynix Inc. stock logo
SKHY
SK hynix
$121.72
-0.4%
$162.91
$117.40
▼
$199.87
$888.57BN/A26.07 million shs11.00 million shs
Tesla, Inc. stock logo
TSLA
Tesla
$380.77
+0.3%
$375.26
$297.38
▼
$498.83
$1.51T1.7449.52 million shs16.89 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-6.02%-19.04%-33.97%-32.41%-50.02%
KLA Corporation stock logo
KLAC
KLA
-5.49%-4.90%-13.14%-26.09%+26.91%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-0.14%+0.48%+7.28%-9.00%-13.74%
QXO, Inc. stock logo
QXO
QXO
-4.53%-12.75%+10.54%-11.01%-31.27%
SK hynix Inc. stock logo
SKHY
SK hynix
-7.29%-9.08%-10.48%-21.49%+12,217,999,900.00%
Tesla, Inc. stock logo
TSLA
Tesla
-2.69%+0.45%+7.05%+12.71%-6.09%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$17.76
-4.3%
$27.43
$13.74
▼
$40.99
$4.13B2.5322.21 million shs9.97 million shs
KLA Corporation stock logo
KLAC
KLA
$142.29
-1.2%
$172.16
$107.20
▼
$307.37
$185.40B1.4911.41 million shs8.67 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$40.53
-2.6%
$39.99
$35.12
▼
$64.16
$181.10B0.716.31 million shs13.03 million shs
QXO, Inc. stock logo
QXO
QXO
$11.22
-6.6%
$11.72
$10.03
▼
$27.61
$11.61B2.4216.58 million shs17.17 million shs
SK hynix Inc. stock logo
SKHY
SK hynix
$121.72
-0.4%
$162.91
$117.40
▼
$199.87
$888.57BN/A26.07 million shs11.00 million shs
Tesla, Inc. stock logo
TSLA
Tesla
$380.77
+0.3%
$375.26
$297.38
▼
$498.83
$1.51T1.7449.52 million shs16.89 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-6.02%-19.04%-33.97%-32.41%-50.02%
KLA Corporation stock logo
KLAC
KLA
-5.49%-4.90%-13.14%-26.09%+26.91%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-0.14%+0.48%+7.28%-9.00%-13.74%
QXO, Inc. stock logo
QXO
QXO
-4.53%-12.75%+10.54%-11.01%-31.27%
SK hynix Inc. stock logo
SKHY
SK hynix
-7.29%-9.08%-10.48%-21.49%+12,217,999,900.00%
Tesla, Inc. stock logo
TSLA
Tesla
-2.69%+0.45%+7.05%+12.71%-6.09%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.13
Hold$31.5377.56% Upside
KLA Corporation stock logo
KLAC
KLA
2.72
Moderate Buy$220.3554.86% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.00
Hold$59.4446.67% Upside
QXO, Inc. stock logo
QXO
QXO
2.79
Moderate Buy$23.79111.94% Upside
SK hynix Inc. stock logo
SKHY
SK hynix
3.13
Buy$247.80103.58% Upside
Tesla, Inc. stock logo
TSLA
Tesla
2.50
Moderate Buy$414.518.86% Upside

Current Analyst Ratings Breakdown

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/17/2026
Tesla, Inc. stock logo
TSLA
Tesla
Reiterated RatingOverweight
11/16/2026
QXO, Inc. stock logo
QXO
QXO
DowngradeSell (D) ➝ Sell (E+)
11/16/2026
SK hynix Inc. stock logo
SKHY
SK hynix
DowngradeHold (C) ➝ Hold (C-)
11/16/2026
QXO, Inc. stock logo
QXO
QXO
Set Price TargetOutperform$21.00
11/13/2026
QXO, Inc. stock logo
QXO
QXO
Lower Price TargetBuy$20.00 ➝ $19.00
11/13/2026
QXO, Inc. stock logo
QXO
QXO
Lower Price TargetOverweight$28.00 ➝ $19.00
11/13/2026
Tesla, Inc. stock logo
TSLA
Tesla
Reiterated RatingSell
11/12/2026
QXO, Inc. stock logo
QXO
QXO
Initiated CoverageNeutral
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetHold$31.00 ➝ $24.00
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetEqual Weight$28.00 ➝ $25.00
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetBuy$42.00 ➝ $32.00
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.35B1.76$0.75 per share23.58$1.52 per share11.68
KLA Corporation stock logo
KLAC
KLA
$13.58B13.65$3.71 per share38.38$5.01 per share28.40
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.80B3.87$4.67 per share8.67$7.51 per share5.40
QXO, Inc. stock logo
QXO
QXO
$6.84B1.70$0.91 per share12.30$12.82 per share0.88
SK hynix Inc. stock logo
SKHY
SK hynix
$68.39B13.00N/AN/AN/A∞
Tesla, Inc. stock logo
TSLA
Tesla
$94.83B15.87$2.55 per share149.23$22.73 per share16.75
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.83N/A591.97N/A-6.65%-9.62%-1.38%N/A
KLA Corporation stock logo
KLAC
KLA
$4.83B$4.0035.5720.301.2936.25%89.30%30.85%2/4/2027 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$3.9710.2211.751.4033.99%53.52%19.49%2/3/2027 (Estimated)
QXO, Inc. stock logo
QXO
QXO
-$279.40M-$0.83N/A23.382.86-5.17%2.41%1.20%N/A
SK hynix Inc. stock logo
SKHY
SK hynix
$30.04B$16.477.393.14N/AN/AN/AN/AN/A
Tesla, Inc. stock logo
TSLA
Tesla
$3.79B$0.91418.44359.2224.623.11%3.03%1.78%1/27/2027 (Estimated)

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/16/2026Q3 2026
SK hynix Inc. stock logo
SKHY
SK hynix
N/A$4.01N/A$4.01N/A$77.05 billion
11/12/2026Q3 2026
QXO, Inc. stock logo
QXO
QXO
$0.1343$0.13-$0.0043-$0.17$4.86 billion$4.90 billion
11/9/2026Q3 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.0563$0.0280-$0.0283-$0.14$893.13 million$890.37 million
10/28/2026Q1 2027
KLA Corporation stock logo
KLAC
KLA
$1.18$1.22+$0.04$1.18$4.04 billion$4.14 billion
10/28/2026Q3 2026
SK hynix Inc. stock logo
SKHY
SK hynix
$5.96$3.84-$2.12$3.84$66.41 billion$73.86 billion
10/21/2026Q3 2026
Tesla, Inc. stock logo
TSLA
Tesla
$0.4550$0.48+$0.0250$0.22$28.06 billion$28.05 billion
8/18/2026Q2 2026
SK hynix Inc. stock logo
SKHY
SK hynix
N/A$8.48N/A$8.48N/A$51.19 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
KLA Corporation stock logo
KLAC
KLA
$0.920.64%+17.32%23.00%16 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.821.97%+21.74%20.65%N/A
QXO, Inc. stock logo
QXO
QXO
N/AN/AN/AN/AN/A
SK hynix Inc. stock logo
SKHY
SK hynix
$0.070.06%N/A0.43%N/A
Tesla, Inc. stock logo
TSLA
Tesla
N/AN/AN/AN/AN/A

Latest HIMS, QXO, KLAC, TSLA, SKHY, and NVO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/5/2026
KLA Corporation stock logo
KLAC
KLA
quarterly$0.230.64%11/16/202611/16/202612/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
3.85
0.92
0.87
KLA Corporation stock logo
KLAC
KLA
0.88
2.76
1.86
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.54
0.84
0.64
QXO, Inc. stock logo
QXO
QXO
0.66
4.11
3.29
SK hynix Inc. stock logo
SKHY
SK hynix
0.06
2.59
2.29
Tesla, Inc. stock logo
TSLA
Tesla
0.09
1.74
1.39

Institutional Ownership

CompanyInstitutional Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
KLA Corporation stock logo
KLAC
KLA
86.65%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%
QXO, Inc. stock logo
QXO
QXO
58.68%
SK hynix Inc. stock logo
SKHY
SK hynix
N/A
Tesla, Inc. stock logo
TSLA
Tesla
66.20%

Insider Ownership

CompanyInsider Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
KLA Corporation stock logo
KLAC
KLA
79.39%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
QXO, Inc. stock logo
QXO
QXO
41.00%
SK hynix Inc. stock logo
SKHY
SK hynix
N/A
Tesla, Inc. stock logo
TSLA
Tesla
20.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442233.31 million206.85 millionOptionable
KLA Corporation stock logo
KLAC
KLA
17,2001.30 billion268.54 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable
QXO, Inc. stock logo
QXO
QXO
7,7941.04 billion612.12 millionOptionable
SK hynix Inc. stock logo
SKHY
SK hynix
35,9297.30 billionN/AOptionable
Tesla, Inc. stock logo
TSLA
Tesla
134,7853.95 billion3.16 billionOptionable

Recent News About These Companies

Own Tesla? You Own A 95% Bet Beyond Cars
Best Energy Stocks To Research - November 17th
Elon Musk Says Tesla’s $299 Cybercab Fee Is “Too High”
Elon Musk Says Tesla's $299 Cybercab Fee Is “Too High”
Tesla (TSLA) Sees $277.5 Million in Net ETF Buying on Friday
Wait for Tesla to Fall to $320: Patience Over FOMO is Paramount
Wait for Tesla to Fall to $320: Patience Over FOMO is Paramount

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$17.76 -0.80 (-4.32%)
As of 03:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

KLA stock logo

KLA NASDAQ:KLAC

$142.29 -1.67 (-1.16%)
As of 03:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

KLA Corporation, together with its subsidiaries, engages in the design, manufacture, and marketing of process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide. It operates through three segments: Semiconductor Process Control; Specialty Semiconductor Process; and PCB and Component Inspection. The company offers inspection and review tools to identify, locate, characterize, review, and analyze defects on various surfaces of patterned and unpatterned wafers; metrology systems that are used to measure pattern dimensions, film thickness, film stress, layer-to-layer alignment, pattern placement, surface topography, and electro-optical properties for wafers; chemical process control equipment; wired and wireless sensor wafers and reticles; wafer defect inspection, review, and metrology systems; reticle inspection and metrology systems; and semiconductor software solutions that provide run-time process control, defect excursion identification, process corrections, and defect classification to accelerate yield learning rates and reduce production risk. It also provides etch, plasma dicing, deposition, and other wafer processing technologies and solutions for the semiconductor and microelectronics industry. In addition, the company offers direct imaging, inspection, optical shaping, inkjet and additive printing, UV laser drilling, and computer-aided manufacturing and engineering solutions for the PCB market; inspection and electrical testing systems to identify and classify defects, as well as systems to repair defects for the display market; and inspection and metrology systems for quality control and yield improvement in advanced and traditional semiconductor packaging markets. The company was formerly known as KLA-Tencor Corporation and changed its name to KLA Corporation in July 2019. KLA Corporation was incorporated in 1975 and is headquartered in Milpitas, California.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$40.52 -1.08 (-2.58%)
As of 03:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

QXO stock logo

QXO NYSE:QXO

$11.22 -0.79 (-6.55%)
As of 03:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

QXO, Inc. operates as a business application, technology, and consulting company in North America. The company provides solutions for accounting and business management, financial reporting, enterprise resource planning, human capital management, warehouse management systems, customer relationship management, and business intelligence. It also offers value-added services that focuses on consulting and professional, specialized programming, training, and technical support services. In addition, the company provides information technology managed services, such as cybersecurity, application hosting, disaster recovery, business continuity, cloud, and other services; and data back-up, network maintenance, and upgrade services. It serves small and medium-sized businesses primarily in the manufacturing, distribution, and service industries. QXO, Inc. is headquartered in Greenwich, Connecticut.

SK hynix stock logo

SK hynix NASDAQ:SKHY

$121.72 -0.46 (-0.38%)
As of 03:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

We are one of the world’s largest memory semiconductor companies and engage in the design, manufacture and sale of advanced memory semiconductors. In the DRAM market that includes HBM, we were ranked second globally based on revenue with a market share of 29.1% in the first quarter of 2026, according to market research conducted by IDC. In the HBM market, we were ranked first globally based on revenue with a market share of 56.4% in the first quarter of 2026, according to IDC. In addition, we were the second largest supplier of NAND flash memory based on revenue, with a worldwide market share of 18.5% in the first quarter of 2026, according to IDC. Our memory products can be used in virtually all electronic devices, including graphics cards, personal computers (“PCs”), data center servers, mobile devices such as smartphones and tablets, and other consumer electronics products. We also conduct our foundry business through SK hynix system ic Inc. (“SK hynix system ic”) and SK keyfoundry Inc. (“SK keyfoundry”), our wholly-owned subsidiaries. We sell a wide variety of DRAM and NAND flash memory products with various configuration options, architectures and performance characteristics tailored to meet application- and customer-specific needs. We believe that we are one of the world’s leading companies in developing DRAMs with advanced specifications, particularly those requiring higher density, faster data-processing speed and lower power consumption. We are continually developing higher-density DRAM modules, SSDs and other advanced DRAM and NAND flash memory products that are optimized for our customers’ specific applications. In recent years, we have substantially increased our sales of HBMs. HBMs are advanced memory semiconductors designed to deliver fast data transfers while using less power, making them especially useful in high-performance applications such as GPUs, AI and high-performance computing. We have focused our sales and marketing activities in recent years on expanding our base of long-term strategic customers. We believe that our expertise and know-how in producing advanced memory semiconductors, strong long-term relationships with our key customers and state-of-the-art global production facilities in key strategic locations provide us with sustainable competitive advantages that will continue to differentiate us from our competitors and enable us to take advantage of attractive growth opportunities. We believe that we are a global leader in the HBM market with advanced production know-how and development of specific configurations that meet our customers’ demands. Our customers seek HBM suppliers with whom they can better align their own product development efforts and their strict quality standards often require HBM manufacturers to comply with rigorous testing and approval processes. We believe that our strengths in HBM, server DRAM and eSSD enable us to mitigate the risks associated with the cyclicality of the memory semiconductor market. We own and operate wafer fabrication facilities (“fabs”) in Icheon and Cheongju, Korea and Wuxi and Dalian, China. We also own and operate assembly and testing facilities for back-end processing of our products in Icheon and Cheongju, Korea and Chongqing, China. As part of our efforts to reduce unit manufacturing costs, improve manufacturing yields and enhance our profitability, we periodically phase out the operations of our older fabs or upgrade them to implement more advanced processing technologies. In addition to regular maintenance and enhancement of existing fabs, in October 2025, we opened the cleanroom of a new extension fab called “M15X” in Cheongju, which we plan to utilize to further increase our production capacity of next-generation DRAMs such as HBM. We began wafer input at the M15X in the first quarter of 2026 and expect to gradually ramp up our production volume. As part of our efforts to ensure our long-term competitiveness, we have also announced initiatives to construct an integrated industrial complex in Yongin, Korea for our next generation of fabs and research and development facilities. We began construction of our first fab at the Yongin complex in February 2025 with the phase 1 cleanroom of the first fab expected to open in the first quarter of 2027. We are currently constructing an advanced packaging plant called “P&T7” in Cheongju and expect to complete construction by the end of 2027. In December 2024, we also announced plans to build an advanced packaging plant in Indiana, United States, and expect to commence operations in the second half of 2028. In order to maintain our technological leadership, as well as to access new markets for our products, we engage in strategic initiatives, including making investments and acquisitions, from time to time. In October 2020, we agreed to acquire the NAND flash memory and storage business of Intel Corporation (“Intel”) (the “Intel NAND Business Acquisition”), including the NAND flash memory manufacturing facility in Dalian, China, NAND flash memory and SSD-related intellectual property and research and development personnel. As consideration for the Intel NAND Business Acquisition, we paid US$6.6 billion in December 2021 and US$2.2 billion in March 2025. We created a subsidiary in the United States to operate the acquired business under the brand name “Solidigm.” We also selectively acquire minority equity positions in other industry players to further strengthen our business relationships and acquire complementary businesses that we believe can further strengthen our leading position in the industry. Our principal executive offices are located in Korea.

Tesla stock logo

Tesla NASDAQ:TSLA

$380.77 +1.03 (+0.27%)
As of 03:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.